CIK 0001773751
- Large accelerated filer
Hims & Hers Health, Inc.
Sign in to watch- Ticker
- HIMS
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-851-0195
- Business address
- 2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
- Former names
- Oaktree Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,483,933
- in 10 filings, $2.5M under 10b5-1 plans
Net −$2,483,933. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-12 | Dudum Andrew Chief Executive Officer | Gift | −1,954,379 | 0 | ||
| 2025-11-12 | Dudum Andrew Chief Executive Officer | Gift | +1,954,379 | 3,004,071 | ||
| 2025-11-10 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −2,637 | $42.53 | $112K | 155,856 |
| 2025-11-10 | Dudum Andrew Chief Executive Officer | Other disposition | −260,000 | 2,423 | ||
| 2025-11-10 | Dudum Andrew Chief Executive Officer | Gift | −1,049,692 | 0 | ||
| 2025-11-10 | Dudum Andrew Chief Executive Officer | Gift | +1,049,692 | 1,049,692 | ||
| 2025-11-07 | Dudum Andrew Chief Executive Officer | Gift | −262,423 | 0 | ||
| 2025-11-07 | Dudum Andrew Chief Executive Officer | Gift | +262,423 | 262,423 | ||
| 2025-10-27 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −2,637 | $50.10 | $132K | 158,493 |
| 2025-10-17 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +7,785 | $5.01 | $39K | 78,017 |
| 2025-10-17 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +3,807 | $11.53 | $44K | 81,824 |
| 2025-10-17 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −11,592 | $57.13 | $662K | 70,232 |
| 2025-10-17 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −7,785 | 174,380 | ||
| 2025-10-17 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −3,807 | 56,169 | ||
| 2025-10-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −2,792 | $62.65 | $175K | 92,523 |
| 2025-10-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −39,111 | $62.70 | $2.5M | 55,947 |
| 2025-10-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −8,423 | $63.46 | $535K | 47,524 |
| 2025-10-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +17,001 | $2.43 | $41K | 109,524 |
| 2025-10-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −17,001 | $62.69 | $1.1M | 92,523 |
| 2025-10-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +108,334 | $2.43 | $263K | 200,857 |
Page 20 of 37 · 739 trades